Leap Investments’s Medifast MED Stock Holding History

Leap Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,200	Closed	-$200K	–	498
2020 Q1	$200K	Buy	+3,200	New	+$291K	0.29%	154

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Leap Investments's MED Position: Q2 2020 in Review

Leap Investments sold out of Medifast (MED) in Q2 2020, closing a stake of 3,200 shares — an estimated $200K sold.

Leap Investments first reported a position in MED in Q1 2020 and held it in 1 quarter. The position peaked at $200K in Q1 2020. 224 funds tracked by Wall St. Rank hold MED as of Q2 2020.

Leap Investments reported no remaining Medifast position as of Q2 2020 after selling out during the quarter.
Leap Investments sold 3,200 Medifast shares in Q2 2020, an estimated $200K.
Leap Investments first reported a position in Medifast in Q1 2020 and held it in 1 quarter.
Leap Investments's Medifast position peaked at $200K in Q1 2020.
224 funds tracked by Wall St. Rank held Medifast as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.